VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
WST
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
WSTWest Pharmaceutical Services, Inc.
$357.64$25.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksWSTQuarterly Financials

West Pharmaceutical Services, Inc. (WST) Quarterly Financials

120+ quarters historyFree accessUpdated daily

West Pharmaceutical Services, Inc. (WST) quarterly income statement — complete revenue, gross profit & net income history

WST Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue844.9M805M804.3M766.2M698.2M748.5M746.9M702M695.3M732.1M747.5M754.2M715.9M708.4M686.4M771.6M719.7M729M706.6M724.1M
Revenue Growth %21.01%7.55%7.69%9.15%0.42%2.24%-0.08%-6.92%-2.88%3.35%8.9%-2.26%-0.53%-2.83%-2.86%6.56%7.26%25.62%28.87%37.43%
Cost of Goods Sold548.5M501.1M510.8M493M465.5M474.1M481.7M470.7M464M453.1M458M462M445.3M445M418.9M451.8M434.9M436.4M418.1M407.7M
COGS % of Revenue64.92%62.25%63.51%64.34%66.67%63.34%64.49%67.05%66.73%61.89%61.27%61.26%62.2%62.82%61.03%58.55%60.43%59.86%59.17%56.3%
Gross Profit296.4M303.9M293.5M273.2M232.7M274.4M265.2M231.3M231.3M279M289.5M292.2M270.6M263.4M267.5M319.8M284.8M292.6M288.5M316.4M
Gross Margin %35.08%37.75%36.49%35.66%33.33%36.66%35.51%32.95%33.27%38.11%38.73%38.74%37.8%37.18%38.97%41.45%39.57%40.14%40.83%43.7%
Gross Profit Growth %27.37%10.75%10.67%18.12%0.61%-1.65%-8.39%-20.84%-14.52%5.92%8.22%-8.63%-4.99%-9.98%-7.28%1.07%4.44%38.35%51.13%62.67%
Operating Expenses119.3M146.8M119.8M115M104.3M103.8M97.4M100.5M104.3M108.4M98.4M104.9M103.1M101.6M79.9M95.9M98M111.7M105M106.5M
OpEx % of Revenue14.12%18.24%14.89%15.01%14.94%13.87%13.04%14.32%15%14.81%13.16%13.91%14.4%14.34%11.64%12.43%13.62%15.32%14.86%14.71%
Selling, General & Admin99.5M106.5M102.7M95.9M88M85.3M81.9M83M86.7M90M89M88.4M86M85.7M66.3M81.5M83.4M98M91.9M92.7M
SG&A % of Revenue11.78%13.23%12.77%12.52%12.6%11.4%10.97%11.82%12.47%12.29%11.91%11.72%12.01%12.1%9.66%10.56%11.59%13.44%13.01%12.8%
Research & Development15.8M21.8M17.1M19.1M16.3M18.5M15.5M17.5M17.6M18.4M16.4M16.5M17.1M15.9M13.6M14.4M14.6M13.7M13.1M13.8M
R&D % of Revenue1.87%2.71%2.13%2.49%2.33%2.47%2.08%2.49%2.53%2.51%2.19%2.19%2.39%2.24%1.98%1.87%2.03%1.88%1.85%1.91%
Other Operating Expenses1000K1000K00000000-1000K000000000
Operating Income177.1M156.6M173.7M158.2M128.4M170.6M167.8M130.8M127M170.6M191.1M187.3M167.5M161.8M187.6M223.9M186.8M180.9M183.5M209.9M
Operating Margin %20.96%19.45%21.6%20.65%18.39%22.79%22.47%18.63%18.27%23.3%25.57%24.83%23.4%22.84%27.33%29.02%25.96%24.81%25.97%28.99%
Operating Income Growth %37.93%-8.21%3.52%20.95%1.1%0%-12.19%-30.17%-24.18%5.44%1.87%-16.35%-10.33%-10.56%2.23%6.67%3.61%47.91%71.98%93.99%
EBITDA173.9M203.6M216.7M199.6M168.4M211.3M208M169.7M162.6M206.5M226.8M221.4M199.1M192.9M217.4M254M216.4M215.3M213.5M238.7M
EBITDA Margin %20.58%25.29%26.94%26.05%24.12%28.23%27.85%24.17%23.39%28.21%30.34%29.36%27.81%27.23%31.67%32.92%30.07%29.53%30.22%32.97%
EBITDA Growth %3.27%-3.64%4.18%17.62%3.57%2.32%-8.29%-23.35%-18.33%7.05%4.32%-12.83%-7.99%-10.4%1.83%6.41%3.34%42.77%53.27%77.6%
D&A (Non-Cash Add-back)047M43M41.4M40M40.7M40.2M38.9M35.6M35.9M35.7M34.1M31.6M31.1M29.8M30.1M29.6M34.4M30M28.8M
EBIT173.9M162.5M174.1M157.1M110.9M164.9M165.2M130.2M128.9M169.3M189.9M187.5M160.1M130.3M138.3M229M189.5M185M182.8M212.8M
Net Interest Income3.2M5.3M4.6M3.5M3.7M4.8M3.9M2.5M4.7M8.3M5.9M2.4M2.6M1.3M-600K-1.4M-1.8M-2.8M-1.3M-1.6M
Interest Income3.2M5.3M4.7M3.6M4.1M4.8M4.6M4M6.2M9.4M8.8M5M4.8M2.9M1.5M400K300K300K400K200K
Interest Expense00100K100K400K0700K1.5M1.5M1.1M2.9M2.6M2.2M1.6M2.1M1.8M2.1M3.1M1.7M1.8M
Other Income/Expense3M8.8M300K3.8M-14.5M-3.7M600K2.4M4.7M900K-400K2.6M-3.9M-29.9M-46.6M8.8M8.2M1M4.1M9.7M
Pretax Income180.1M165.4M174M162M113.9M166.9M168.4M133.2M131.7M171.5M190.7M189.9M163.6M131.9M141M232.7M195M181.9M187.6M219.6M
Pretax Margin %21.32%20.55%21.63%21.14%16.31%22.3%22.55%18.97%18.94%23.43%25.51%25.18%22.85%18.62%20.54%30.16%27.09%24.95%26.55%30.33%
Income Tax44.7M33.3M34M30.2M24.1M36.8M32.4M21.9M16.4M34.5M29.4M34.8M23.6M28.9M20.4M44.2M21.2M34.2M12M32.3M
Effective Tax Rate %24.82%20.13%19.54%18.64%21.16%22.05%19.24%16.44%12.45%20.12%15.42%18.33%14.43%21.91%14.47%18.99%10.87%18.8%6.4%14.71%
Net Income138.8M132.1M140M131.8M89.8M130.1M136M111.3M115.3M137M161.3M155.1M140M103M120.6M188.5M173.8M147.7M175.6M187.3M
Net Margin %16.43%16.41%17.41%17.2%12.86%17.38%18.21%15.85%16.58%18.71%21.58%20.56%19.56%14.54%17.57%24.43%24.15%20.26%24.85%25.87%
Net Income Growth %54.57%1.54%2.94%18.42%-22.12%-5.04%-15.69%-28.24%-17.64%33.01%33.75%-17.72%-19.45%-30.26%-31.32%0.64%14.95%50.1%113.37%105.37%
Net Income (Continuing)135.4M132.1M140M131.8M89.8M130.1M136M111.3M115.3M137M161.3M155.1M140M103M120.6M188.5M173.8M147.7M175.6M187.3M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)1.921.821.931.821.231.781.851.511.551.832.142.061.851.361.592.492.291.932.312.47
EPS Growth %56.1%2.25%4.32%20.53%-20.65%-2.73%-13.55%-26.7%-16.22%34.56%34.59%-17.27%-19.21%-29.53%-31.17%0.81%15.08%49.61%111.93%104.13%
EPS (Basic)1.931.831.941.821.241.791.871.521.571.852.172.091.881.381.622.532.341.982.372.53
Diluted Shares Outstanding72.4M72.7M72.7M72.8M73M73.7M73.4M73.7M74.3M75M75.3M75.4M75.7M75.6M75.7M75.8M76M76.4M76M75.7M
Basic Shares Outstanding72M72.3M72.3M72.3M72.5M73M72.8M73M73.5M74.1M74.3M74.3M74.5M74.4M74.4M74.4M74.4M74.5M74.1M74M
Dividend Payout Ratio-11.96%10.79%11.46%16.93%11.76%10.66%13.12%12.75%10.8%8.68%9.09%10.07%13.69%11.19%6.95%7.71%9%7.18%6.73%